US Stock MarketDetailed Quotes

BOLD Boundless Bio

Watchlist

3.270
+0.100+3.15%

Trading Nov 7 11:03 ET

72.77MMarket Cap-1260P/E (TTM)

Boundless Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-49.09%-16.24M

-30.49%-15.78M

-18.33%-46.86M

-14.76%-11.69M

-12.86%-12.19M

-10.89M

-12.09M

-70.32%-39.6M

-10.18M

-10.8M

Net income from continuing operations

-36.93%-16.98M

-31.67%-15.43M

-7.70%-49.43M

-3.10%-12.14M

-0.37%-13.17M

---12.4M

---11.72M

-82.07%-45.9M

---11.78M

---13.13M

Depreciation and amortization

11.34%265K

10.97%263K

1.59%957K

3.35%247K

-4.47%235K

--238K

--237K

38.12%942K

--239K

--246K

Other non cash items

17.29%631K

10.75%618K

39.96%2.39M

31.61%687K

-16.62%602K

--538K

--558K

302.84%1.7M

--522K

--722K

Change In working capital

-217.17%-587K

4.87%-1.58M

-192.26%-799K

-171.15%-180K

-20.47%544K

--501K

---1.66M

203.46%866K

--253K

--684K

-Change in prepaid assets

-833.33%-1.15M

-211.56%-701K

-60.83%85K

-64.05%87K

38.96%346K

---123K

---225K

113.55%217K

--242K

--249K

-Change in payables and accrued expense

7.22%1.25M

76.77%-210K

-12.98%1.66M

-1.08%549K

62.55%855K

--1.16M

---904K

56.13%1.91M

--555K

--526K

-Change in other current liabilities

-27.27%-686K

-25.61%-672K

-101.82%-2.55M

-50.00%-816K

-621.98%-657K

---539K

---535K

-174.95%-1.26M

---544K

---91K

Cash from discontinued investing activities

Operating cash flow

-49.09%-16.24M

-30.49%-15.78M

-18.33%-46.86M

-14.76%-11.69M

-12.86%-12.19M

---10.89M

---12.09M

-70.32%-39.6M

---10.18M

---10.8M

Investing cash flow

Cash flow from continuing investing activities

0.48%-68.19M

-18.18%18.14M

-337.17%-38.26M

89.05%15.81M

-190.41%-7.72M

-68.52M

22.17M

127.21%16.13M

8.36M

8.54M

Net PPE purchase and sale

-1,075.00%-1.5M

3.49%-83K

40.62%-633K

-587.18%-268K

-32.46%-151K

---128K

---86K

47.59%-1.07M

---39K

---114K

Net investment purchase and sale

2.49%-66.69M

-18.12%18.22M

-318.79%-37.63M

91.36%16.08M

-187.47%-7.57M

---68.39M

--22.25M

130.04%17.2M

--8.4M

--8.65M

Cash from discontinued investing activities

Investing cash flow

0.48%-68.19M

-18.18%18.14M

-337.17%-38.26M

89.05%15.81M

-190.41%-7.72M

---68.52M

--22.17M

127.21%16.13M

--8.36M

--8.54M

Financing cash flow

Cash flow from continuing financing activities

-9.08%90.65M

-3,080.65%-924K

77,596.03%97.9M

-4,054.29%-1.38M

-1,115.91%-447K

99.7M

31K

-99.88%126K

35K

44K

Net preferred stock issuance

----

--99.67M

--0

---329K

----

--0

Proceeds from stock option exercised by employees

--0

90.32%59K

44.44%182K

11.43%39K

95.45%86K

--26K

--31K

-39.42%126K

--35K

--44K

Net other financing activities

---2.35M

---983K

---1.96M

---1.42M

---204K

----

Cash from discontinued financing activities

Financing cash flow

-9.08%90.65M

-3,080.65%-924K

77,596.03%97.9M

-4,054.29%-1.38M

-1,115.91%-447K

--99.7M

--31K

-99.88%126K

--35K

--44K

Net cash flow

Beginning cash position

19.04%25.7M

111.30%24.27M

-67.02%11.48M

62.22%21.52M

170.38%41.88M

--21.59M

--11.48M

194.38%34.82M

--13.27M

--15.49M

Current changes in cash

-69.34%6.22M

-85.78%1.44M

154.77%12.78M

253.70%2.74M

-816.80%-20.35M

--20.29M

--10.11M

-201.50%-23.34M

---1.78M

---2.22M

End cash Position

-23.77%31.92M

19.04%25.7M

111.30%24.27M

62.22%21.52M

--41.88M

--21.59M

-67.02%11.48M

--11.48M

--13.27M

Free cash flow

-61.01%-17.74M

-30.25%-15.86M

-16.79%-47.49M

-16.94%-11.95M

-13.07%-12.34M

---11.02M

---12.18M

-60.83%-40.66M

---10.22M

---10.91M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-49.09%-16.24M	-30.49%-15.78M	-18.33%-46.86M	-14.76%-11.69M	-12.86%-12.19M	-10.89M	-12.09M	-70.32%-39.6M	-10.18M	-10.8M
Net income from continuing operations	-36.93%-16.98M	-31.67%-15.43M	-7.70%-49.43M	-3.10%-12.14M	-0.37%-13.17M	---12.4M	---11.72M	-82.07%-45.9M	---11.78M	---13.13M
Depreciation and amortization	11.34%265K	10.97%263K	1.59%957K	3.35%247K	-4.47%235K	--238K	--237K	38.12%942K	--239K	--246K
Other non cash items	17.29%631K	10.75%618K	39.96%2.39M	31.61%687K	-16.62%602K	--538K	--558K	302.84%1.7M	--522K	--722K
Change In working capital	-217.17%-587K	4.87%-1.58M	-192.26%-799K	-171.15%-180K	-20.47%544K	--501K	---1.66M	203.46%866K	--253K	--684K
-Change in prepaid assets	-833.33%-1.15M	-211.56%-701K	-60.83%85K	-64.05%87K	38.96%346K	---123K	---225K	113.55%217K	--242K	--249K
-Change in payables and accrued expense	7.22%1.25M	76.77%-210K	-12.98%1.66M	-1.08%549K	62.55%855K	--1.16M	---904K	56.13%1.91M	--555K	--526K
-Change in other current liabilities	-27.27%-686K	-25.61%-672K	-101.82%-2.55M	-50.00%-816K	-621.98%-657K	---539K	---535K	-174.95%-1.26M	---544K	---91K
Cash from discontinued investing activities
Operating cash flow	-49.09%-16.24M	-30.49%-15.78M	-18.33%-46.86M	-14.76%-11.69M	-12.86%-12.19M	---10.89M	---12.09M	-70.32%-39.6M	---10.18M	---10.8M
Investing cash flow
Cash flow from continuing investing activities	0.48%-68.19M	-18.18%18.14M	-337.17%-38.26M	89.05%15.81M	-190.41%-7.72M	-68.52M	22.17M	127.21%16.13M	8.36M	8.54M
Net PPE purchase and sale	-1,075.00%-1.5M	3.49%-83K	40.62%-633K	-587.18%-268K	-32.46%-151K	---128K	---86K	47.59%-1.07M	---39K	---114K
Net investment purchase and sale	2.49%-66.69M	-18.12%18.22M	-318.79%-37.63M	91.36%16.08M	-187.47%-7.57M	---68.39M	--22.25M	130.04%17.2M	--8.4M	--8.65M
Cash from discontinued investing activities
Investing cash flow	0.48%-68.19M	-18.18%18.14M	-337.17%-38.26M	89.05%15.81M	-190.41%-7.72M	---68.52M	--22.17M	127.21%16.13M	--8.36M	--8.54M
Financing cash flow
Cash flow from continuing financing activities	-9.08%90.65M	-3,080.65%-924K	77,596.03%97.9M	-4,054.29%-1.38M	-1,115.91%-447K	99.7M	31K	-99.88%126K	35K	44K
Net preferred stock issuance	----	----	--99.67M	--0	---329K	----	----	--0	--0	--0
Proceeds from stock option exercised by employees	--0	90.32%59K	44.44%182K	11.43%39K	95.45%86K	--26K	--31K	-39.42%126K	--35K	--44K
Net other financing activities	---2.35M	---983K	---1.96M	---1.42M	---204K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-9.08%90.65M	-3,080.65%-924K	77,596.03%97.9M	-4,054.29%-1.38M	-1,115.91%-447K	--99.7M	--31K	-99.88%126K	--35K	--44K
Net cash flow
Beginning cash position	19.04%25.7M	111.30%24.27M	-67.02%11.48M	62.22%21.52M	170.38%41.88M	--21.59M	--11.48M	194.38%34.82M	--13.27M	--15.49M
Current changes in cash	-69.34%6.22M	-85.78%1.44M	154.77%12.78M	253.70%2.74M	-816.80%-20.35M	--20.29M	--10.11M	-201.50%-23.34M	---1.78M	---2.22M
End cash Position	-23.77%31.92M	19.04%25.7M	111.30%24.27M	111.30%24.27M	62.22%21.52M	--41.88M	--21.59M	-67.02%11.48M	--11.48M	--13.27M
Free cash flow	-61.01%-17.74M	-30.25%-15.86M	-16.79%-47.49M	-16.94%-11.95M	-13.07%-12.34M	---11.02M	---12.18M	-60.83%-40.66M	---10.22M	---10.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data